Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (21093)	4/21/1999 7:53:00 PM
From: Amots	Read Replies (1) \| Respond to of 23519

VLAD. A remainder of the last CC: Message 7540425 <<It will be a challenge to be profitable in Q1 &Q2 due to slow regulatory approval" Leland >> I don't think he jump the gun like he did last year.

To: VLAD who wrote (21093)	4/21/1999 7:57:00 PM
From: wvalx	Read Replies (1) \| Respond to of 23519

VLAD, I am more than willing to hear an honest opposing opinion. I just think people are missing the point about the break even statement. Increasing revenues + more drugs in pipline = increase in share price.

To: VLAD who wrote (21093)	4/21/1999 8:13:00 PM
From: RT	Read Replies (4) \| Respond to of 23519

VLAD, May I have your permission to say something? I don't mean to offend you your Royal Hiny but shouldn't Curtis be allowed the right to express his opinion? Comparing him to Jack Garnes requires a quantum leap of imagination even for blankmind. RT